With an aim to ensure quality home healthcare services to the people at affordable rate, HealthCare atHOME (HCAH), India’s leading provider of technology-driven home-based medical services, is all set to expand its footprint pan India and in all metro cities in the country by the end of 2017.
Started by Dabur India's promoter Burman family and founders of UK-based Healthcare at Home, the company will soon start its services in Hyderabad, the capital of Southern Indian state of Telangana and Andhra Pradesh. As of now HCAH is present in Delhi NCR, Mumbai, Punjab, Jaipur, Bengaluru, Pune, Indore and more. Around 2,000 personnel will be hired by the company by the end of the year to meet expansion requirements. Currently, it is operating with a team of 800 personnel in 30 + cities in B2B segment, 6 cities in B2C segment including Delhi/NCR, Punjab, Mumbai, Jaipur, Bengaluru and Hyderabad which will soon witness its presence and 12 cities in pharmacy segment, said CEO and Co-founder of HCAH, Vivek Srivastava.
At present we offer a wide range of services covering around 70 per cent of all healthcare requirements of a patient starting from nominal wound dressing to strengthening your back muscles like physiotherapy and performing complex procedures at home like cancer treatment, ICU and extends to management of lifestyle and chronic diseases like diabetes, etc. over consumer’s lifetime. Here the expansion strategy is to widen our geographical reach and broaden our width of services so as to be truly seen as a distributed hospital, he said.
Additionally, the company is focusing to build B2B business. It partners with pharmaceuticals to provide services covering the complete patient journey starting from disease awareness to disease detection, treatment initiation, drug distribution, disease management, compliance management and showcasing clinical outcomes. With insurance companies it would be in pre and post policy checks. Some of its services are getting cashless approval by insurance companies. It also conducts ergonomics, stress management and other similar seminars for employees from corporates. It engages with hospitals to help them in achieving average length of stay reduction and extending community reach and engagement.
So far HCAH has assembled more than 300 ICU set ups spanning over 2,000 + ICU days managed at home and conducted more than 500 oncology procedures including chemotherapy at home.
The company which recently tied up with Critinext, Asia's largest e-ICU network, is open for tying up with enterprises to expand its bouquet of services and improve quality of service.
Started with a corpus of Rs. 200 crore, the company is set to achieve break-even over a couple of years. So far no external funding was resorted by it, said co-founder and chief executive officer, HCAH.
Sharing HCAH vision for 2020, he stated that by 2020 we have plans to reach out to cities having 20 lakh population in the country as well as abroad, expand operations with top pharma and insurance companies in the country. We wish to garner a significant share of the market by increasing a bouquet of services we offered to patients and expanding number of contracts with pharma companies as well as furthering pharmacy product transactions. We have targeted to clock Rs. 1,000 crore revenue by 2020.
Talking about trends driving home healthcare market, he added, “Increased awareness among people about home healthcare, insurance companies' increased coverage and traditional healthcare providers including doctors and hospitals' increasing reliance on enterprises providing outpatient care have contributed to the growth of home healthcare ventures in India. The country's aging population and increasing cases of chronic diseases due to lifestyle disorders, among others, have been driving the home healthcare market. Globally home healthcare market constitutes 3-6 per cent of healthcare market. Indian home healthcare market is estimated to reach USD 8.4 billion by 2020.”